Formyl-Peptide Receptor 2 Signaling Modulates SLC7A11/xCT Expression and Activity in Tumor Cells

被引:0
|
作者
Cimmino, Tiziana Pecchillo [1 ]
Punziano, Carolina [1 ]
Panico, Iolanda [1 ]
Petrone, Zeudi [1 ]
Cassese, Myrhiam [1 ]
Faraonio, Raffaella [1 ]
Barresi, Vincenza [2 ]
Esposito, Gabriella [1 ]
Ammendola, Rosario [1 ]
Cattaneo, Fabio [1 ]
机构
[1] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy
[2] Univ Catania, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy
关键词
formyl-peptide receptor 2; NADPH oxidase; glutathione; lipid peroxidation; NRF2; CYSTINE/GLUTAMATE ANTIPORTER; MOLECULAR-MECHANISMS; SYSTEM X(C)(-); NADPH OXIDASES; NOX FAMILY; CANCER; ROS; LOCALIZATION; PEROXIDATION; FERROPTOSIS;
D O I
10.3390/antiox13050552
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer cells exhibit high levels of oxidative stress and consequently require a high amount of cysteine for glutathione synthesis. Solute Carrier Family 7 Member 11 (SLC7A11), or xCT, mediates the cellular uptake of cystine in exchange for intracellular glutamate; imported extracellular cystine is reduced to cysteine in the cytosol through a NADPH-consuming reduction reaction. SLC7A11/xCT expression is under the control of stress-inducing conditions and of several transcription factors, such as NRF2 and ATF4. Formyl-peptide receptor 2 (FPR2) belongs to the FPR family, which transduces chemotactic signals mediating either inflammatory or anti-inflammatory responses according to the nature of its ligands and/or FPR2 binding with other FPR isoforms. The repertoire of FPR2 agonists with anti-inflammatory activities comprises WKYMVm peptide and Annexin A1 (ANXA1), and the downstream effects of the intracellular signaling cascades triggered by FPR2 include NADPH oxidase (NOX)-dependent generation of reactive oxygen species. Herein, we demonstrate that stimulation of CaLu-6 cells with either WKYMVm or ANXA1: (i) induces the redox-regulated activation of SLC7A11/xCT; (ii) promotes the synthesis of glutathione; (iii) prevents lipid peroxidation; and (iv) favors NRF2 nuclear translocation and activation. In conclusion, our overall results demonstrate that FPR2 agonists and NOX modulate SLC7A11/xCT expression and activity, thereby identifying a novel regulative pathway of the cystine/glutamate antiport that represents a new potential therapeutical target for the treatment of human cancers.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells
    Luo, Jing
    Yu, Hongmei
    Yuan, Zhen
    Ye, Tao
    Hu, Bo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (07) : 2265 - 2276
  • [42] Decreased mRNA expression for the two subunits of system xc-, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia
    Lin, Chieh-Hsin
    Lin, Pei-Pei
    Lin, Chun-Yuan
    Lin, Ching-Hua
    Huang, Chiung-Hsien
    Huang, Yu-Jhen
    Lane, Hsien-Yuan
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 72 : 58 - 63
  • [43] Gardenoside attenuates Staphylococcus aureus-induced mastitis by inhibiting inflammation and ferroptosis through Nrf2/SLC7A11/GPX4 signaling pathway
    Sui, Guoqing
    Jiang, Wei
    Guan, Lianyue
    MICROBIOLOGY SPECTRUM, 2025, 13 (01)
  • [44] LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma
    Jin, Dong
    Hui, Yongfeng
    Liu, Di
    Li, Nan
    Leng, Junzhi
    Wang, Genwang
    Wang, Qi
    Lu, Zhenhui
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (01)
  • [45] Dihydroartemisinin induces ferroptosis in T cell acute lymphoblastic leukemia cells by downregulating SLC7A11 and activating the ATF4-CHOP signaling pathway
    Tang, Na
    Liu, Xinling
    Liu, Yong
    Wang, Haihua
    Zhao, Yao
    Wang, Haiying
    Hu, Zhenbo
    ONCOLOGY LETTERS, 2024, 28 (01)
  • [46] Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis
    Yuan, Bing
    Liao, Feng
    Shi, Zhi-Zhou
    Ren, Yuan
    Deng, Xiao-Li
    Yang, Ting-Ting
    Li, Deng-Yuan
    Li, Ru-Fang
    Pu, Dan-Dan
    Wang, Yu-Jue
    Tan, Yan
    Yang, Zhen
    Zhang, Yun-Hui
    ONCOTARGETS AND THERAPY, 2020, 13 : 10829 - 10840
  • [47] CircDUSP22 Attenuates the Ferroptosis of Prostate Cancer Cells via miR-18a-5p/SLC7A11/GPX4 Signaling
    Jiang, Hua
    Zhang, He
    Jiang, Songsong
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
  • [48] Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling
    Zhu, Bingwen
    Ni, Yufang
    Gong, Yi
    Kang, Xiaoshuang
    Guo, Huaiying
    Liu, Xiaoheng
    Li, Jianchun
    Wang, Li
    LIFE SCIENCES, 2023, 315
  • [49] Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway
    Shi, Mengjiao
    Li, Xinyan
    Guo, Ying
    Zhang, Yinggang
    Xu, Jiayi
    Yan, Liangwen
    Liu, Rongrong
    Wang, Hong
    Tang, Shenkang
    Zhao, Yaping
    Li, Zongfang
    Feng, Yetong
    Ren, Dongmei
    Liu, Pengfei
    ADVANCED SCIENCE, 2025,
  • [50] p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells
    Li, Xurui
    Xiong, Wei
    Wang, Yinhuai
    Li, Yijian
    Cheng, Xu
    Liu, Wentao
    LABORATORY INVESTIGATION, 2023, 103 (05)